TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/24 16:54 | 5/16/24 | DNA | Ginkgo Bioworks Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dekkers Marijn E | MA | D | S | -220 | 0.8303 | 0 | -265 | -4 | 5,797 | I | |||||||||||||||
5/14/24 17:13 | 5/14/24 | DNA | Ginkgo Bioworks Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dekkers Marijn E | MA | D | S | -1,606 | 0.9300 | 0 | -1,727 | -22 | 6,062 | D | |||||||||||||||
6/20/23 16:56 | 6/15/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dekkers Marijn E | MA | D | S | -6,886 | 34.43 | 0 | -200 | -32 | 434 | I | |||||||||||||||
11/7/22 21:34 | 11/3/22 | DNA | Ginkgo Bioworks Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dekkers Marijn E | MA | D | S | -439 | 2.56 | 0 | -171 | -2 | 7,801 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |